Difference between revisions of "FDA"
From Gomerpedia
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | [[File:Food and Drug Administration (United States) (logo).jpg| | + | [[File:Food and Drug Administration (United States) (logo).jpg|100|px|thumb|right]] |
'''FDA''', once stood for the Food & Drug Administration, now stands for the '''Fentanyl & [[Dilaudid (Hydromorphone)|Dilaudid]] Administration'''. | '''FDA''', once stood for the Food & Drug Administration, now stands for the '''Fentanyl & [[Dilaudid (Hydromorphone)|Dilaudid]] Administration'''. | ||
Line 6: | Line 6: | ||
'''FDA Approvals''' | '''FDA Approvals''' | ||
---- | ---- | ||
− | |||
#On October 21, 2014, the '''FDA''' approved Furosesonerolaquinox - which is a combination of Lasix, Solu-Medrol, albuterol, Levaquin, and Lovenox - for the treatment of shortness of breath.<ref>[http://gomerblog.com/2014/10/dyspnea/ FDA Approves “FUROSESONEROLAQUINOX” for Undifferentiated Dyspnea]</ref> | #On October 21, 2014, the '''FDA''' approved Furosesonerolaquinox - which is a combination of Lasix, Solu-Medrol, albuterol, Levaquin, and Lovenox - for the treatment of shortness of breath.<ref>[http://gomerblog.com/2014/10/dyspnea/ FDA Approves “FUROSESONEROLAQUINOX” for Undifferentiated Dyspnea]</ref> | ||
#On March 22, 2015, the '''FDA''' approved the H-Vape 86 or [[Ativan Diffuser|Ativan diffuser]] for inpatient hospital use in order to help offset the difficulties of yelling patients, high patient-to-nurse ratios, and patients who are relentless with the [[Call Light|call light]].<ref>[http://gomerblog.com/2015/03/ativan-diffuser/ FDA Finally Approves The Ativan Diffuser for All Hospital Units]</ref> | #On March 22, 2015, the '''FDA''' approved the H-Vape 86 or [[Ativan Diffuser|Ativan diffuser]] for inpatient hospital use in order to help offset the difficulties of yelling patients, high patient-to-nurse ratios, and patients who are relentless with the [[Call Light|call light]].<ref>[http://gomerblog.com/2015/03/ativan-diffuser/ FDA Finally Approves The Ativan Diffuser for All Hospital Units]</ref> | ||
Line 24: | Line 23: | ||
− | ''' | + | '''References''' |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
---- | ---- | ||
<references /> | <references /> |
Revision as of 11:57, 29 January 2017
FDA, once stood for the Food & Drug Administration, now stands for the Fentanyl & Dilaudid Administration.
FDA Approvals
- On October 21, 2014, the FDA approved Furosesonerolaquinox - which is a combination of Lasix, Solu-Medrol, albuterol, Levaquin, and Lovenox - for the treatment of shortness of breath.[1]
- On March 22, 2015, the FDA approved the H-Vape 86 or Ativan diffuser for inpatient hospital use in order to help offset the difficulties of yelling patients, high patient-to-nurse ratios, and patients who are relentless with the call light.[2]
- On April 30, 2015, the FDA announced the development of a breakthrough medication for the treatment of status dramaticus called normale saline, which is best given by a fast push then walking away.[3]
- On June 19, 2015, the FDA approved the drug Nomega, being the first medication on the market to have absolutely no adverse or therapeutic effects.[4]
- On June 24, 2015, the FDA approved a prosthetic robotic penis to help treat erectile dysfunction.[5]
- On April 18, 2015, the FDA approved Merck's Priapic (mycoxaflopin) for the treatment of both bacterial infections and male impotence.[6]
- On August 21, 2015, the FDA approved OxyContin for children under the condition that they are "yay high."[7]
- On July 20, 2016, the FDA granted approval for Bovie to cut government red tape.[8]
- On January 28, 2017, the FDA approved a postmortem chemotherapy to be administered up to 5 years after a patient's death.[9]
FDA Bans
- On April 7, 2014, the FDA banned insulin after data conclusively showed that insulin was associated with heart disease, obesity, retinopathy, nephropathy, and neuropathy.[10]
- On August 2, 2015, the FDA banned the production and use of any narcotic that contains the letter D or a vowel in it in a hope to curb the opioid crisis.[11]
References
- ↑ FDA Approves “FUROSESONEROLAQUINOX” for Undifferentiated Dyspnea
- ↑ FDA Finally Approves The Ativan Diffuser for All Hospital Units
- ↑ Exciting New Treatment for “Status Dramaticus” Released Today by the FDA and NIH
- ↑ Nomega Approved by FDA
- ↑ Pioneering Bionics Company Gains FDA Approval for Robotic Penis
- ↑ FDA Approves First Antibiotic/Male Impotence Drug: Mycoxaflopin
- ↑ FDA Approves OxyContin for Kids Tall Enough to Get on This Ride
- ↑ Bovie™ Electrocautery Receives FDA Approval for Cutting Red Tape
- ↑ FDA Approves Groundbreaking Postmortem Chemotherapy Protocol
- ↑ FDA Bans Insulin Amid Reports of Increased Amputations and Other Life Threatening Diseases
- ↑ FDA Bans Any Narcotic with the Letter “D” In It